DESMOPLASTIC SMALL ROUND CELL TUMOR
Clinical trials for DESMOPLASTIC SMALL ROUND CELL TUMOR explained in plain language.
Never miss a new study
Get alerted when new DESMOPLASTIC SMALL ROUND CELL TUMOR trials appear
Sign up with your email to follow new studies for DESMOPLASTIC SMALL ROUND CELL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancer: testing drug combo for relapsed tumors
Disease control OngoingThis study is testing whether adding the drug ramucirumab to standard chemotherapy can help control a rare and aggressive cancer called desmoplastic small round cell tumor (DSRCT) in children and young adults whose cancer has returned or stopped responding to previous treatments.…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug combo tested for tough childhood cancers
Disease control OngoingThis study is testing a new combination of drugs for young patients (up to age 25) with high-risk Ewing sarcoma and desmoplastic small round cell tumors. Patients are divided into two groups: those with lower-risk tumors receive standard treatment, while those with higher-risk tu…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for kids with tough cancers: scientists test 'Re-Trained' immune cells
Disease control OngoingThis early-stage study is testing a new type of personalized cell therapy for children and young adults whose solid tumors have come back or haven't responded to other treatments. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack cance…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for kids with tough cancers: genetically engineered immune cells target tumors
Disease control OngoingThis early-phase study is testing the safety and feasibility of a new treatment called CAR T-cell therapy for children and young adults whose solid tumors have come back or not responded to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to be…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC